Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease

Protocol No
PULM-VERACYTE-ENVISIA-ILD
Phase
N/A
Summary

This project is being done to evaluate the impact of a genomic test, Envisia, in the diagnosis and management of your lung disease.

Description
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL